154 related articles for article (PubMed ID: 11979833)
21. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
22. [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
Sugano K
Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():32-7. PubMed ID: 11989260
[No Abstract] [Full Text] [Related]
23. [Adverse effects of Helicobacter pylori eradication and its prevention].
Zhang S; Yanaka A
Nihon Rinsho; 2005 Nov; 63 Suppl 11():414-7. PubMed ID: 16363570
[No Abstract] [Full Text] [Related]
24. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
25. [H. pylori eradication package set (Lansap)].
Kawai T; Kawakami K; Moriyasu F; Takagi Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():361-5. PubMed ID: 16363560
[No Abstract] [Full Text] [Related]
26. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
28. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Inoue K; Sugano K
Nihon Rinsho; 2002 Feb; 60 Suppl 2():460-4. PubMed ID: 11979828
[No Abstract] [Full Text] [Related]
29. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
[TBL] [Abstract][Full Text] [Related]
30. [Proton pump inhibitors: Rabeprazole].
Yoshino J
Nihon Rinsho; 2002 Feb; 60 Suppl 2():645-9. PubMed ID: 11979863
[No Abstract] [Full Text] [Related]
31. [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Mitsuno Y; Yoshida H
Nihon Rinsho; 2002 Feb; 60 Suppl 2():452-4. PubMed ID: 11979826
[No Abstract] [Full Text] [Related]
32. Causal role of Helicobacter pylori in peptic ulcer relapse.
Asaka M; Ohtaki T; Kato M; Kudo M; Kimura T; Meguro T; Horita S; Inoue K
J Gastroenterol; 1994 Jul; 29 Suppl 7():134-8. PubMed ID: 7921146
[TBL] [Abstract][Full Text] [Related]
33. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Oka M; Ichinose M; Fujishiro M; Omata M
Nihon Rinsho; 2005 Nov; 63 Suppl 11():461-4. PubMed ID: 16363579
[No Abstract] [Full Text] [Related]
34. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Kawano S; Murakami M; Saita H; Tsuji S
J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
36. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
Müller P; Simon B
Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
38. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
39. [Guidelines in the management of Helicobacter pylori infection in Japan].
Asaka M
Nihon Rinsho; 2003 Feb; 61 Suppl 2():703-8. PubMed ID: 12722304
[No Abstract] [Full Text] [Related]
40. [Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Fu HY; Kawano S; Tanimura H
Nihon Rinsho; 2002 Feb; 60 Suppl 2():423-6. PubMed ID: 11979819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
